161 related articles for article (PubMed ID: 35839075)
1. Defective RAB31-mediated megakaryocytic early endosomal trafficking of VWF, EGFR, and M6PR in RUNX1 deficiency.
Jalagadugula G; Mao G; Goldfinger LE; Wurtzel J; Del Carpio-Cano F; Lambert MP; Estevez B; French DL; Poncz M; Rao AK
Blood Adv; 2022 Sep; 6(17):5100-5112. PubMed ID: 35839075
[TBL] [Abstract][Full Text] [Related]
2. Defective RAB1B-related megakaryocytic ER-to-Golgi transport in RUNX1 haplodeficiency: impact on von Willebrand factor.
Jalagadugula G; Goldfinger LE; Mao G; Lambert MP; Rao AK
Blood Adv; 2018 Apr; 2(7):797-806. PubMed ID: 29632235
[TBL] [Abstract][Full Text] [Related]
3. Altered platelet-megakaryocyte endocytosis and trafficking of albumin and fibrinogen in RUNX1 haplodeficiency.
Del Carpio-Cano F; Mao G; Goldfinger LE; Wurtzel J; Guan L; Alam MA; Lee K; Poncz M; Rao AK
Blood Adv; 2024 Apr; 8(7):1699-1714. PubMed ID: 38330198
[TBL] [Abstract][Full Text] [Related]
4. Engagement of the small GTPase Rab31 protein and its effector, early endosome antigen 1, is important for trafficking of the ligand-bound epidermal growth factor receptor from the early to the late endosome.
Chua CE; Tang BL
J Biol Chem; 2014 May; 289(18):12375-89. PubMed ID: 24644286
[TBL] [Abstract][Full Text] [Related]
5. Dysregulation of PLDN (pallidin) is a mechanism for platelet dense granule deficiency in RUNX1 haplodeficiency.
Mao GF; Goldfinger LE; Fan DC; Lambert MP; Jalagadugula G; Freishtat R; Rao AK
J Thromb Haemost; 2017 Apr; 15(4):792-801. PubMed ID: 28075530
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of platelet factor 4 (PF4) deficiency with RUNX1 haplodeficiency: RUNX1 is a transcriptional regulator of PF4.
Aneja K; Jalagadugula G; Mao G; Singh A; Rao AK
J Thromb Haemost; 2011 Feb; 9(2):383-91. PubMed ID: 21129147
[TBL] [Abstract][Full Text] [Related]
7. RUNX1 and TGF-β signaling cross talk regulates Ca
Raghuwanshi S; Dahariya S; Sharma DS; Kovuru N; Sahu I; Gutti RK
FEBS J; 2020 Dec; 287(24):5411-5438. PubMed ID: 32281291
[TBL] [Abstract][Full Text] [Related]
8. Altered Platelet-Megakaryocyte Endocytosis and Trafficking of Albumin and Fibrinogen in
Carpio-Cano FD; Mao G; Goldfinger LE; Wurtzel J; Guan L; Alam AM; Lee K; Poncz ME; Rao AK
medRxiv; 2023 Oct; ():. PubMed ID: 37961544
[TBL] [Abstract][Full Text] [Related]
9. Human
Li Y; Jin C; Bai H; Gao Y; Sun S; Chen L; Qin L; Liu PP; Cheng L; Wang QF
Blood; 2018 Jan; 131(2):191-201. PubMed ID: 29101237
[TBL] [Abstract][Full Text] [Related]
10. RUNX1 suppression induces megakaryocytic differentiation of UT-7/GM cells.
Nagai R; Matsuura E; Hoshika Y; Nakata E; Nagura H; Watanabe A; Komatsu N; Okada Y; Doi T
Biochem Biophys Res Commun; 2006 Jun; 345(1):78-84. PubMed ID: 16674921
[TBL] [Abstract][Full Text] [Related]
11. RUNX1-deficient human megakaryocytes demonstrate thrombopoietic and platelet half-life and functional defects.
Lee K; Ahn HS; Estevez B; Poncz M
Blood; 2023 Jan; 141(3):260-270. PubMed ID: 36219879
[TBL] [Abstract][Full Text] [Related]
12. RUNX1/core binding factor A2 regulates platelet 12-lipoxygenase gene (ALOX12): studies in human RUNX1 haplodeficiency.
Kaur G; Jalagadugula G; Mao G; Rao AK
Blood; 2010 Apr; 115(15):3128-35. PubMed ID: 20181616
[TBL] [Abstract][Full Text] [Related]
13. Platelet protein kinase C-theta deficiency with human RUNX1 mutation: PRKCQ is a transcriptional target of RUNX1.
Jalagadugula G; Mao G; Kaur G; Dhanasekaran DN; Rao AK
Arterioscler Thromb Vasc Biol; 2011 Apr; 31(4):921-7. PubMed ID: 21252065
[TBL] [Abstract][Full Text] [Related]
14. Defective acid hydrolase secretion in RUNX1 haplodeficiency: Evidence for a global platelet secretory defect.
Rao AK; Poncz M
Haemophilia; 2017 Sep; 23(5):784-792. PubMed ID: 28662545
[TBL] [Abstract][Full Text] [Related]
15. A critical role of RUNX1 in governing megakaryocyte-primed hematopoietic stem cell differentiation.
Wang C; Tu Z; Cai X; Wang W; Davis AK; Nattamai K; Paranjpe A; Dexheimer P; Wu J; Huang FL; Geiger H; Huang G; Zheng Y
Blood Adv; 2023 Jun; 7(11):2590-2605. PubMed ID: 36661340
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms underlying platelet function defect in a pedigree with familial platelet disorder with a predisposition to acute myelogenous leukemia: potential role for candidate RUNX1 targets.
Glembotsky AC; Bluteau D; Espasandin YR; Goette NP; Marta RF; Marin Oyarzun CP; Korin L; Lev PR; Laguens RP; Molinas FC; Raslova H; Heller PG
J Thromb Haemost; 2014 May; 12(5):761-72. PubMed ID: 24606315
[TBL] [Abstract][Full Text] [Related]
17. Suppression of RUNX1 by siRNA in megakaryocytic UT-7/GM cells.
Okada Y; Nagai R; Matsuura E; Hoshika Y; Nakata E; Nagura H; Watanabe A; Komatsu N; Doi T
Nucleic Acids Symp Ser (Oxf); 2006; (50):261-2. PubMed ID: 17150917
[TBL] [Abstract][Full Text] [Related]
18. Regulation of platelet myosin light chain (MYL9) by RUNX1: implications for thrombocytopenia and platelet dysfunction in RUNX1 haplodeficiency.
Jalagadugula G; Mao G; Kaur G; Goldfinger LE; Dhanasekaran DN; Rao AK
Blood; 2010 Dec; 116(26):6037-45. PubMed ID: 20876458
[TBL] [Abstract][Full Text] [Related]
19. A novel membrane targeting domain mediates the endosomal or Golgi localization specificity of small GTPases Rab22 and Rab31.
Banworth MJ; Liang Z; Li G
J Biol Chem; 2022 Sep; 298(9):102281. PubMed ID: 35863437
[TBL] [Abstract][Full Text] [Related]
20. Impaired hematopoietic differentiation of RUNX1-mutated induced pluripotent stem cells derived from FPD/AML patients.
Sakurai M; Kunimoto H; Watanabe N; Fukuchi Y; Yuasa S; Yamazaki S; Nishimura T; Sadahira K; Fukuda K; Okano H; Nakauchi H; Morita Y; Matsumura I; Kudo K; Ito E; Ebihara Y; Tsuji K; Harada Y; Harada H; Okamoto S; Nakajima H
Leukemia; 2014 Dec; 28(12):2344-54. PubMed ID: 24732596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
